11β-hydroxylase deficiency other diagnostic studies
11β-hydroxylase deficiency Microchapters |
Differentiating 11β-hydroxylase deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
11β-hydroxylase deficiency other diagnostic studies On the Web |
American Roentgen Ray Society Images of 11β-hydroxylase deficiency other diagnostic studies |
11β-hydroxylase deficiency other diagnostic studies in the news |
Blogs on 11β-hydroxylase deficiency other diagnostic studies |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
Risk calculators and risk factors for 11β-hydroxylase deficiency other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Prenatal diagnosis may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are:amniotic fluid 11-deoxycortisol and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies; and utilize fetal DNA extracted from maternal blood through noninvasive methods.
Other Diagnostic Studies
Prenatal diagnosis may be used in diagnosis of congenital adrenal hyperplasia. Different tests which may be used are:
- Amniotic fluid 11-deoxycortisol and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies.
- Utilize fetal DNA extracted from maternal blood through noninvasive methods.[1]
References
- ↑ Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T (2017). "New developments in prenatal diagnosis of congenital adrenal hyperplasia". J. Steroid Biochem. Mol. Biol. 165 (Pt A): 121–123. doi:10.1016/j.jsbmb.2016.06.016. PMID 27378492.